key: cord-0840687-jsgzgsme authors: Tack, Jan; Schol, Jolien; Geeraerts, Annelies; Huang, I‐Hsuan; Mori, Hideki; Scarpellini, Emidio; Sinonquel, Pieter; Carbone, Florencia; Colomier, Esther; Geysen, Hannelore; Jandee, Sawangpong; Moonen, An; Pannemans, Jasper; Timmermans, Lien; Van den Houte, Karen; Verbeure, Wout; Wauters, Lucas; Bisschops, Raf; Hoffman, Ilse; Roelandt, Philip; Rommel, Nathalie; Simren, Magnus; Suzuki, Hidekazu; Tornblom, Hans; Verbeke, Kristin; Vanuytsel, Tim title: A survey on the impact of the COVID‐19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase date: 2020-06-01 journal: Neurogastroenterol Motil DOI: 10.1111/nmo.13926 sha: e6e1bb0810bdd9931b47f6b8225cee94609a354c doc_id: 840687 cord_uid: jsgzgsme BACKGROUND: The COVID‐19 pandemic, declared by WHO on March 13(th) 2020, had a major global impact on the health care system and services. In the acute phase, the presence of the SARS‐CoV‐2 virus in the aerodigestive tract limited activities in the gastroenterology clinic and procedures to emergencies only. Motility and function testing was interrupted and as we enter the recovery phase, restarting these procedures requires a safety‐focused approach with adequate infection prevention for patients and healthcare professionals. METHODS: We summarized knowledge on the presence of the SARS‐CoV‐2 virus in the aerodigestive tract and the risk of spread with motility and functional testing. We surveyed 39 European centers documenting how the pandemic affected activities and which measures they are considering for restarting these measurements. We propose recommendations based on current knowledge as applied in our center. RESULTS: Positioning of catheters for gastrointestinal motility tests carries a concern for aerosol‐borne infection of health care workers. The risk is low with breath tests. The surveyed centers stopped almost all motility and function tests from the second half of March. The speed of restarting and the safety measures taken varied highly. CONCLUSIONS AND INFERENCES: Based on these findings, we provided recommendations and practical relevant information for motility and function test procedures in the COVID‐19 pandemic era, to guarantee a high‐quality patient care with adequate infection prevention. Since the end of 2019, the world has seen rapidly spreading cases of a pneumonia and acute respiratory distress syndrome, caused by the transmission of a novel coronavirus, named SARS-CoV-2 by the World Health Organisation (WHO), causing the disease COVID-19 (1, 2) . Governments throughout the World have tried to contain the spread of this highly contagious disease through strict isolation measures and a focus of healthcare systems, staff and services on COVID-19 cases, while suspending care for all but essential and urgent medical conditions (3) (4) (5) (6) (7) (8) . Early May 2020, the infection rates have decreased in Europe and a gradual resumption of non-urgent medical services is proposed. In the gastroenterology specialty, several guidelines have been issued on how to select and safely conduct endoscopic procedures during the phase of urgent-care only (6) (7) (8) (9) , and early guidance is issued for the recommencing of procedures in the deceleration and early recovery phases of the pandemic (9) (10) (11) . This is done with careful precautions, as endoscopies are aerosol generating procedures with considerable risk of infection to other patients and endoscopy staff when performed on a SARS-CoV-2 infected individual (6) (7) (8) (9) (10) (11) . Besides endoscopy, motility and function test procedures in gastroenterology units were also interrupted with the focus on urgent procedures. As motility and functional disorders are a large part of gastroenterology clinical practice, the question arises when and how to resume diagnostic testing for these conditions. Indeed, breath tests and insertion of upper gastrointestinal manometry and pH monitoring probes carry a risk for viral spread through droplet formation when probes pass the nose or mouth and pharynx, or when air is blown into breath test tubes (12) . The aim of this paper is to summarize the current knowledge and recommendations, to describe the impact of the COVID-19 pandemic on motility and function testing in gastroenterology practice in Europe, and to provide some practical guidance for the protective restoration of motility and function testing. This article is protected by copyright. All rights reserved. We performed a Pubmed, Medline and Embase search between the 26 th of April and the 10 th of May 2020 using 'SARS-CoV-2', 'COVID-19', '(esophageal) manometry', '(esophageal) pH monitoring', 'anorectal manometry' and 'breath test' as MeSH terms. We also searched websites of gastroenterology and motility societies for information on procedures and 'SARS-CoV-2', 'COVID-19' or 'Corona virus'. In addition, we conducted a Pubmed, Medline and Embase search using 'gastrointestinal endoscopy', 'endoscopy, digestive system endoscopy' as MeSH terms for general protective measures for staff and patients in endoscopy units. We only used published data, reports and articles written in the English language. We summarized available literature for content and extrapolated from endoscopy guidance to develop guidance towards performing motility and functional testing procedures in the early recovery phases of the COVID-19 pandemic. To assess the impact of the pandemic on motility and function testing in Europe, we generated a questionnaire in Qualtrics XM for European clinicians with an interest in this pathology based on their involvement in recent consensus documents and on membership of the European Society for Neurogastroenterology and Motility. The following gastrointestinal activities were included: esophageal manometry, catheterbased pH-monitoring, wireless pH-monitoring (Bravo ® ), anorectal manometry and breath tests. The questions aimed at evaluating whether the center reduced or stopped motility and functional testing, and if so at what time and to which extent. The questions also assessed estimated timing for restarting these activities and at what capacity. Additionally, the questions also evaluated which protection measures and screening methods the center would be using during the restart of these activities. This article is protected by copyright. All rights reserved. Many countries affected by the pandemic are now entering a post-peak period, where disease levels in countries with adequate surveillance are dropping below the observed peak levels (2, 13) . This phase may or may not be followed by additional waves of transient rises of infectious activity (1, 2, 13) . The British Society of Gastroenterology distinguishes build-up, peak and deceleration phases, where hospital facilities are repurposed for managing the infected case load besides urgent non-infection care (11) . In the post-peak period, admissions decrease and requisitioned beds are gradually returned to normal services. This is followed by a phase of late recovery, where the case load falls and hospital configuration and activity is close to normal, although localized reactivations may still occur (11) . Hence, there is a persisting risk of patients carrying the infection even after the peak and recovery episodes, which may be of low prevalence, but needs to be taken into account when planning procedures. Symptoms of COVID-19 infection are often those of a common cold (runny nose, sneezing, fatigue, cough), a body temperature of 37.5℃ or higher and dysgeusia and dysosmia, without apparent cause (9, 14, 15) . In addition, there may also be digestive symptoms (see below). The highest viral loads of SARS-CoV-2 are found in the nasopharynx, and the virus mainly spreads directly via droplets and aerosols, and indirectly by contact with contaminated surfaces (14, 15) . Transmission by infected persons may already occur in the pre-symptomatic phase (14) . SARS-CoV-2 enters cells via the angiotensin converting enzyme 2 (ACE2) receptor, which is expressed not only in the lungs but also on blood vessels, in the brain, the skin and the digestive system (15) . ACE2 is highly expressed in esophageal epithelial cells, on gastric glandular cells and on enterocytes in the small bowel and the colon, which explains gastrointestinal manifestations of the infection (15) (16) (17) . Gastrointestinal symptoms in COVID-19 This article is protected by copyright. All rights reserved. patients include decreased appetite, loss of taste, nausea, vomiting, abdominal pain, diarrhea and possibly lower gastrointestinal bleeding (16) (17) (18) . Positive stool (real time) reverse transcription polymerase chain reaction ((RT-)PCR) tests for SARS-CoV-2 have been reported and fecal tests may be positive when a respiratory test is or has become negative (16, 19) . These observations support the possibility of fecal-oral transmission (16, 19, 20) . Fifteen centers stopped their activities immediately and 9 centers gradually reduced activities before completely stopping this type of investigations. Eleven centers reduced their activities with 50% (n=1), 80% (n=4) and 90% (n=6), as they still were performing some urgent esophageal manometries (e.g. pre-surgery). This article is protected by copyright. All rights reserved. Furthermore, COVID-19 majorly impacted catheter-based pH-monitoring investigations, as 36/39 centers reduced or stopped these activities on the 16 th of March 2020 (range 29 th of February 2020 -6 th of April 2020). These centers reduced their capacity with a median of 100% (80-100%). Twenty-two centers stopped their activities immediately, while 6 centers gradually reduced activities before completely stopping this type of investigations and 5 centers reduced their activities with 80% (n=2) and 90% (n=3). In addition, there was a significant impact of COVID-19 on the wireless pH-capsule testing. Nineteen centers did not perform this type of test, and 13 out of 15 centers who offered it reduced or stopped performing wireless pH testing on the 16 th of March 2020 (9 th of March 2020 -1 st of April 2020). The capacity was reduced with 100% (range 80-100%). Twelve centers stopped their activities immediately and only 1 center did not completely halt Bravo ® pH capsule investigations (80%). Thirty centers performed breath tests before the start of the COVID-19 pandemic. Twenty-six centers reduced their capacity with a median of 100% (40-100%) from the 16 th of March 2020 (26 th of February 2020 -6 th of April 2020) onwards. Five centers reduced their activities with only 40% (n=1) and 90% (n=4).Three centers did not change their capacity for performing breath tests due to COVID-19. Breath tests were immediately reduced in 23 centers, while five centers gradually reduced before complete stopping all activities. Two centers did not clarify if activities were stopped gradually or not. This article is protected by copyright. All rights reserved. The 14 centers that already restarted with at least one of the discussed investigations concerning gastrointestinal motility testing, were able to restart after a median of 49 days (34 -71 days), including all motility tests that were discussed earlier. However, centers that have not been able to restart yet, estimated to restart after a median of 79 days, on the 1 st of June (42 -171 days). Three centers did not have a perspective on when to restart activities in general and three centers provide no estimate a time point to restart performing breath tests. All centers that already started or still have to restart activities, estimate to restart at 55% of initial capacity for esophageal manometry (20-100%), 50% for pH monitoring (20-100%), 60% for the Bravo ® pHcapsule (10-100%), 50% of initial capacity (30-100%) for anal manometry, and 50% for breath tests (10-100%). Currently, the most frequently used protection measures when performing motility testing included an FFP2 mask, a face shield, a hairnet, a water-resistant gown and standard gloves (Table 1) . For anorectal manometry, a surgical mask was regularly used as well. The most common screening procedures, currently or expected to be used by the contacted centers to detect possible COVID-19 infection prior to performing investigations, were anamnestic risk assessment and temperature check ( Table 2) . Before performing esophageal manometry, catheter-based pH monitoring or tests with the Bravo ® pH-capsule, a PCR-swab for acute COVID-19 infection diagnosis was also frequently applied. One center did not decide yet which screening procedures will be used in the near future. This article is protected by copyright. All rights reserved. Prior to performing any type of endoluminal procedure of the gastrointestinal tract, a general assessment of the urgency and need of the procedure, as well as the associated risk for patients as well as healthcare workers, is strongly recommended. We outline the approach based on the literature review, as is being implemented in our center. The vast majority of motility and functional disorders are chronic and non-urgent, without life-threatening complications (33) . Diagnostic endoscopy is likely to precede any upper gastrointestinal motility and functional testing to rule out organic disease. Moreover, empirical treatment is available for several conditions, such as PPIs for GERD and anti-emetics for nausea/vomiting disorders. Most procedures therefore can be postponed and only need to be considered in the late recovery phases of the pandemic. Exceptions are dysphagia where only fluids can be managed, dysphagia either oropharyngeal or esophageal, that is associated with aspiration and aspiration pneumonia, and intractable nausea and vomiting with electrolyte imbalances or weight loss. In these conditions, further exploration is recommended within the first 2 to 4 weeks, and this may include (pharyngo-)esophageal manometry and breath testing (mainly gastric emptying). All endoluminal procedures, especially in the upper gastrointestinal tract, should be considered high-risk procedures if the patient is infected, even if asymptomatic (14) (15) (16) (17) . However, considering all patients potentially infected places high demand on supplies of high-level personal protective equipment (PPE) and slows down procedures because of the time required for preparation, more comprehensive room cleaning and air circulation between procedures (7). An alternative approach is to determine the presence of active infection by a combination of the clinical presentation, RT-PCR-test (nasopharyngeal swab and/or This article is protected by copyright. All rights reserved. in rare cases bronchoalveolar lavage) and/or multi-sliced chest computed tomography (CT) scan although the value of the latter in screening is questionable (34, 35) . This information can then be combined to determine the level of protective measures needed. Detection of viral RNA by PCR, which has moderate to high sensitivity depending on timing and type of test, has become a mainstay of COVID-19 disease detection, also in asymptomatic subjects (10, 34, 35) . This method has been recommended for identifying patients with active infection prior to elective endoscopy, and we recommend the same approach for risk management with broad testing prior to function testing procedures involving upper gastrointestinal tract intubation (10) . However, this technique has several limitations including the need for technical expertise, the occurrence of false negative results and an inability to detect individuals who may be immune (37, 3) . It has been recommended to consider a negative PCR test valid for 48 hours (10) . Anal swabs have also been explored but seem to be inconsistent and, at best, positive in later stages of the infection (4, 15, 16) . Antibody testing probably has the potential to play a supplementary role to PCR in diagnosis, screening of contacts and possibly in the determination of population immunity. However, there is a lack of standardized, reliable tests, and sensitivity varies with the stage of infection (40) . If the test is considered necessary and urgent, PCR testing as described above should be performed (10, 34, 35) . In case no testing is available, the patient needs to be considered as potentially infected and high-level PPE and room handling procedures need to be used (Figure 1 ). This article is protected by copyright. All rights reserved. without risk factor and a negative laboratory RT-PCR test (10) . In case of 1 risk factor and negative PCR, the patient is still considered low-risk. For low-risk patients, a COVID-minimized track can be followed, with more targeted use of PPE and lowerintensity procedures. Given the variable reliability of possible tests and their results in combination with the possible spectrum of symptoms, there is an inherent lingering uncertainty about the patient's COVID-19 status (5, 9) . Therefore, systematic general protective measures and the use of different levels of PPE is recommended for all motility procedures (5). On the other hand, in the Leuven University Hospitals, systematic PCR tests were positive in only 2% of asymptomatic patients screened prior to elective endoscopy This article is protected by copyright. All rights reserved. procedures (9) . Hence, low-risk assessment, based on a combination of absence of risk factors, symptoms and a negative nasopharyngeal swab seems to hold a low risk for contamination during the procedure and justifies less stringent measures to save on limited protective resources. Specific recommendations for management of motility function units are summarized in Table 3 . Table 4 summarizes the protective measures for staff in case of low-risk or unknown-risk status of the patient. Personnel wears dedicated hospital clothing when performing clinical tasks. The sequence of dressing and undressing with these PPE is specific and should be followed in the correct order at all times to avoid patient to health care worker transmission. The dressing-procedure is called 'the donning' and the undressingprocedure is called 'the doffing'. Illustrative videos are available on www.uzleuven.be/nl/covid-19-voor-woonzorgcentra/omkleedprocedure. The donning procedure consists of 8 steps (Figure 2a , Table 5 ). The doffing procedure consists of the same 8 steps but in an altered sequence and every step is separated from another by disinfecting your hands with alcohol. Step 1 to 3 are inside of the room, or in a separate dedicated room, for the removal of disposable PPE, step 4 to 6 are outside of the room for collection of recyclable face shield, goggles and mask. Due to its scarcity, specialized cleaning and sterilization programs have been implemented for these items after recollection (Figure 2b , Table 6 ). Since contamination is most likely to happen because of errors during the "undressing/doffing" procedure, leading to accidental contact with the contaminated mask, goggles or front of the gown, extra awareness and supervised training for this procedure is advisable. The face shield, goggles and FFP2/3-mask should be taken off after putting on a new pair of nitrile gloves outside of the room, to minimize possible transmission to the health care worker's skin while taking off these protection items, which can be highly contaminated. Removal of the surgical hat and disinfection of the hand with alcohol as final step are considered standard of care (step 7 and 8). This article is protected by copyright. All rights reserved. Most of the upper gastrointestinal function tests, including (pharyngo-)esophageal manometry and pH(-MII) monitoring, involve the positioning of a catheter through the nasopharynx which is the region containing the highest viral load in COVID-19 positive patients (40) . During the insertion of the catheter, aerosols can be produced, especially when the patient starts coughing or sneezing resulting from local irritation. Although no specific data are available in the literature related to the SARS-CoV-2 transmission risk during placement of nasogastric tubes or manometry devices, this procedure should be considered high-risk based on the localization (nasopharynx) and the risk of aerosol formation. Based on the assumed high risk of the procedure, combined with the possibility to postpone the procedure for at least two weeks, manometry and pH-MII monitoring should preferably only be performed in low-risk patients, i.e. with a negative RT-PCR test and without any signs (fever) or symptoms suggestive of COVID-19 (cf. supra). In case testing cannot be performed, the patient needs to be considered uncertain risk with more extensive PPE measures. The height of the bed should be adjusted in a way that the upper part of the head of the patient is under the chin of the nurse or technician. We recommend applying lubricating gel containing a local anesthetic on the catheter and to avoid the use of sprays with local anesthetic because of the risk of aerosol formation (41) . During the insertion of the catheter, the mask should still be worn over the mouth, exposing the nose only. The monitor and manometry setup should be positioned at the maximal distance of the patient and protection with a plastic removable cover should be considered. Prior to the start of the measurement, the patient's mask can be removed. We recommend that the boluses are still administered using a syringe to protect the quality of the test, but this should be done while maintaining a maximal distance. During assessment of patients with oropharyngeal dysphagia, boluses that are known to trigger coughing in the patient should be avoided. Overall, the time devoted to the assessment This article is protected by copyright. All rights reserved. procedures should be restricted as much as possible. Before removal of the catheter at the end of the measurement, the mask should be repositioned over the mouth. Regular disinfection procedures of the manometry probe suffice since the standard biocidal solutions and wipes demonstrate an effective inactivation of coronaviruses (42) . Additionally, the manometry setup, keyboard, computer screen, desk and headboard of the bed should be wiped with standard biocidal wipes between two patients. Regular cleaning of the floor is also needed as this is where many aerosol droplets may end. The main risk of pH-MII measurement procedure lies in the positioning of the catheter for which the same precautionary measures, including patient selection, apply as for esophageal manometry. After each use, the portable registration device should be wiped with biocidal wipes. As an alternative, the portable registration device can be wrapped in transparent plastic which is sealed with tape, eliminating direct contact with body and body fluids, while allowing screen checking and use of buttons. Moreover, we recommend using single-use or washable holders and shoulder straps for the recorder. Since virtually all pH-MII probes are single-use catheters, specific disinfection protocols do not apply. The catheter-free pH-monitoring system can be used as an alternative, although there is no clear preference for one or the other in the current pandemic. The wireless pH-capsule is positioned by the gastroenterologist, using the delivery system, usually preceded by a gastroscopy with the general safety procedures for endoscopy (7, 9) . An additional limitation is that the capsule only quantifies acid reflux. Investigation of dyschezia or fecal incontinence is hardly ever urgent and should be restricted to low-risk patients. Although no oropharyngeal manipulations are This article is protected by copyright. All rights reserved. performed, close proximity to the patient is required and therefore patients should keep wearing a mask throughout the test. Prior to anorectal manometry a water enema can be given in case of fecal loading of the rectum. As defecation is considered an aerogenic process and SARS-CoV-2 particles potentially can be shed via feces, a toilet in a separate room is preferred over in-room commode seat. In all cases, toilet or commode seats should be disinfected between patients. During measurement of resting pressure, but especially during measurement of squeezing pressure and simulated defecation, seepage of fecal content can occur. Therefore, staff should wear PPE throughout the entire procedure, based on the above-mentioned risk stratification. Similar to esophageal manometry, reusable anorectal manometry catheters should be disinfected with standard biocidal solutions, as well as setup, computer, keyboard, bed/stretcher and toilet/commode. Although breath tests do not require pharyngeal passage with a catheter, there is a theoretical risk of virus particle dispersion through aerosolized breaths. For 13 C and for H2-based breath tests, the patient blows a breath sample via a straw into a tube that is subsequently sealed (43) (44) (45) . While one cannot exclude minor aerosol production from saliva during this repetitive sample collection where the subject has to blow out alveolar air, this is likely to be minimal (30, 46) . The patient should remain in the dedicated test room during the test. As the patient can perform this test independently, it is probably sufficient for staff to maintain a distance of 1.5m, for the patient to wash their hands before and after the test with soap or disinfectant, and to clean the table before and after the test with disinfectant wipes. Sample handling and storing should be done wearing protective gloves, and the tubes should be carried in isolation plastic bags. If required, storage for further analysis should be in dedicated shelve sections. This article is protected by copyright. All rights reserved. With 14 C breath tests, the risk of aerosol generation is greater as the patient blows via a straw into a liquid-filled vial until color change occurs (43) . However, as the liquid consists of 70% EtOH, which is a disinfectant in its own right, the risk seems contained. The same hygienic and disinfectant measures as outlined for 13 C and for H2-based breath tests can also be applied. The isotope ratio mass spectrometer used to measure 13 CO2 enrichment has a syringe with a needle that sucks the air into the system. The needle and syringe should be regularly disinfected after analysis of the suspect/positive patient samples. A filter can be positioned at the outlet section of the spectrometer and regularly changed, avoiding operator contamination. Personnel involved in the analysis should wear appropriate PPE while handling sample tubes. H2-based tests are usually analysed with either a gas-chromatography with thermal conductivity detection or portable instruments based on an electrochemical cell (344. As gas chromatographs are particularly sensitive to the humidity transferred with the breath sample, they often contain a chemical based water trap that needs periodical replacement (44) . A particular attention has to be paid for protection of staff when changing this filter after analyzing samples of suspect/positive COVID-19 patients, and personnel involved in the analysis should wear appropriate PPE when changing the filter as well as when handling sample tubes. Portable H2-analyzers in which the patient directly blows via a mouthpiece, are protected by a dedicated filter that traps airborne bacteria and viruses. Similar precautions as above are needed when removing the disposable mouthpiece and when replacing this filter. This article is protected by copyright. All rights reserved. The outbreak of the COVID-19 pandemic has had a major impact on healthcare delivery across the world. In the build-up, peak and deceleration phase of the pandemic, the healthcare system focused on management of patients with COVID-19 infection and urgent other care (2, 7, 8) . Motility and functional disorder care shifted to the background because of the non-urgent and chronic nature of these pathologies. However, these are highly prevalent conditions with a major impact on patients and society, and hence both diagnostic and therapeutic care of these patients needs to be restored in the post-peak period (33, 47) . This needs to be done with awareness of the persisting risk of infection being present in and spreading from a small group of patients (5, 6, 11) . Several guidelines have been published on patient selection and staff and patient protection when performing endoscopies during the different phases of the pandemic, but such guidance has been lacking for functional and motility disorders and has mostly been limited to acknowledging their non-urgent status (5) (6) (7) (8) (9) 11) . Based on a survey we conducted in 31 centers in Europe, motility and function testing was practically abandoned throughout the continent during the peak phase of the pandemic, starting second half of March and continuing well into May 2020. In almost all centers the number of procedures was diminished by 100% or at least by 90%. We also documented that most centers are (preparing to be) starting up again by June, although some centers do not have a formal start-up date determined at this point. All centers plan precautions to screen for infected patients, and to protect staff and other patients from infection related to motility and function testing, but the type and scope of measures show tremendous variation. For protection of medical personnel, different types of masks, facial shield, gloves and gowns will be applied. There is occasional use of negative pressure rooms and shoe covers. For detection of acute infection, there is a high, though not uniform, use of anamnestic evaluation and temperature check. Approximately half of the centers will use PCR on throat swabs to screen patients. Next, we proposed a practical guide for clinical practice based on the precedent for endoscopy and the currently limited understanding of the SARS-CoV-2 infection. The This article is protected by copyright. All rights reserved. Sars-CoV-2 infection is a highly contagious new disease which primarily spreads via droplets from the naso-oropharynx, but may also be present in the lower gastrointestinal tract. Hence, the risk of transmission needs to be taken into account when planning and performing motility and function testing. Screening for infection in patients and protection of the medical staff, using targeted PPE measures, are the key factor to avoid further spreading and procedure-related extra infections. This article is protected by copyright. All rights reserved. ccepted Article This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. 3. Linear patient and staff flow through the unit (no crossing of COVID positive and negative pathways, separate entrance and exit). 4. Similar separate in-and outflow for material used in procedures. 5. Preferential use of single use and disposable material. 11. Building a platform for all employees to quickly communicate and sending important messages to every staff member. This article is protected by copyright. All rights reserved. 3. Diligent hand hygiene for at least 20 seconds, before and after patient contact. The same before and after material contact. 4. Avoiding touching the face (in particular eyes, nose, and mouth). 5. Appropriate PPE should be available for each type of functional test for all staff and patients involved. 6. In patients classified as low risk, PPE should include gloves, a hairnet, protective eyewear (goggles or face shield), gowns and surgical masks. 7. In patients with unknown or high risk COVID-19 status, PPE should include waterproof gowns, booties/shoe covers, a hairnet, protective eyewear (goggles or face shield), and a level 2 PPE with FFP2/FFP3-mask and two pairs of gloves. This article is protected by copyright. All rights reserved. 5. Put on a surgical hat or hairnet. 6. Put on a surgical or FFP2/3-mask (adjust correctly around the nose and beneath the chin). 7. Put on the goggles over the surgical or FFP2/3-mask. 8. Put on the face shield if required. 9. Put on a second pair of (short) nitrile gloves if required. In some centers an additional apron is worn. 3. Remove the long nitrile gloves. 4. Take off the face shield and put in a recycle bin for collection 5. Take of the goggles (from behindover the head, do not touch the front or glasses) and put them in the same recycle bin as the face shield for collection 6. Take of the FFP2/3-mask (from behindover the head, do not touch the front) into a second recycle bin for collection. Coronavirus disease 2019 (COVID-19): A literature review COVID-19) situation report -110. World Health Organization Gastroenterology Practice in COVID-19 Pandemic The daily impact of COVID-19 in gastroenterology Special attention to nurses' protection during the COVID-19 epidemic. Crit Care What constitutes urgent endoscopy? A social media snapshot of gastroenterologists' views during the COVID-19 pandemic Endosc Int Open COVID-19 and gastrointestinal endoscopy: what should be taken into account? Dig Endosc COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis BSG Guidance on recommencing GI Endoscopy in the deceleration & early recovery phases of the COVID-19 pandemic recommencing-gi-endoscopy-in-the-deceleration-early-recovery-phases-ofthe-covid-19-pandemic International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders Pandemic Influenza Preparedness and Response: A WHO Guidance Document Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic. Emerg Infect Dis Xiao-Sheng Wang Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission Sars-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease Cases With SARS-CoV-2 Infection Gut Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Metaanalysis Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020 Management of refractory typical GERD symptoms How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery) Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease: A Systematic Review International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry Gastrointestinal Manifestations of Rheumatological Diseases Small Bowel Motility Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus All members of the International Anorectal Physiology Working Group. The international anorectal physiology working group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia Diagnostic value and key features of computed tomography in Coronavirus Disease CT screening for early diagnosis of SARS-CoV-2 infection. Lancet infectious diseases Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients Laboratory diagnosis of emerging human coronavirus infections -the state of the art SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Anaesthesia and SARS Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Methods and functions: Breath tests Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference Breath tests for the assessment of the orocecal transit time Breath tests with (13)C substrates Functional gastrointestinal disorders as a public health problem This article is protected by copyright. All rights reserved.